BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wang TH, Lin JT, Chen DS, Sheu JC, Sung JL. Noninvasive diagnosis of advanced pancreatic cancer by real-time ultrasonography, carcinoembryonic antigen, and carbohydrate antigen 19-9. Pancreas 1986;1:219-23. [PMID: 3554223 DOI: 10.1097/00006676-198605000-00004] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.3] [Reference Citation Analysis]
Number Citing Articles
1 Lafrance ND, Brooks K, Yin D, Parker JR, Bensel K, Macchi D, Lev-toaff AS. Preliminary cost-effectiveness evaluation of an oral sonographic contrast agent using a decision modeling technique. Academic Radiology 1996;3:S426-31. [DOI: 10.1016/s1076-6332(96)80606-4] [Cited by in Crossref: 3] [Article Influence: 0.1] [Reference Citation Analysis]
2 Poruk KE, Gay DZ, Brown K, Mulvihill JD, Boucher KM, Scaife CL, Firpo MA, Mulvihill SJ. The clinical utility of CA 19-9 in pancreatic adenocarcinoma: diagnostic and prognostic updates. Curr Mol Med. 2013;13:340-351. [PMID: 23331006 DOI: 10.2174/1566524011313030003] [Cited by in Crossref: 19] [Cited by in F6Publishing: 87] [Article Influence: 2.4] [Reference Citation Analysis]
3 Homma T, Tsuchiya R. The study of the mass screening of persons without symptoms and of the screening of outpatients with gastrointestinal complaints or icterus for pancreatic cancer in Japan, using CA19-9 and elastase-1 or ultrasonography. Int J Pancreatol 1991;9:119-24. [PMID: 1744437 DOI: 10.1007/BF02925587] [Cited by in F6Publishing: 12] [Reference Citation Analysis]
4 Lamerz R. CA 19–9, GICA (Gastrointestinal Cancer Antigen). In: Sell S, editor. Serological Cancer Markers. Totowa: Humana Press; 1992. pp. 309-39. [DOI: 10.1007/978-1-4612-0401-5_14] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.2] [Reference Citation Analysis]
5 Audisio RA, Veronesi P, Maisonneuve P, Chiappa A, Andreoni B, Bombardieri E, Geraghty JG. Clinical relevance of serological markers in the detection and follow-up of pancreatic adenocarcinoma. Surg Oncol 1996;5:49-63. [PMID: 8853239 DOI: 10.1016/s0960-7404(96)80001-6] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
6 Jung KW, Kim MH, Lee TY, Kwon S, Oh HC, Lee SS, Seo DW, Lee SK. Clinicopathological aspects of 542 cases of pancreatic cancer: a special emphasis on small pancreatic cancer. J Korean Med Sci 2007;22 Suppl:S79-85. [PMID: 17923760 DOI: 10.3346/jkms.2007.22.S.S79] [Cited by in Crossref: 20] [Cited by in F6Publishing: 11] [Article Influence: 1.5] [Reference Citation Analysis]
7 Boyd EJ, Rinderknecht H, Wormsley KG. Laboratory tests in the diagnosis of the chronic pancreatic diseases. Part 6. Differentiation between chronic pancreatitis and pancreatic cancer. Int J Pancreatol 1988;3:229-40. [PMID: 3290345 DOI: 10.1007/BF02788452] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
8 Su SB, Qin SY, Chen W, Luo W, Jiang HX. Carbohydrate antigen 19-9 for differential diagnosis of pancreatic carcinoma and chronic pancreatitis. World J Gastroenterol 2015;21:4323-33. [PMID: 25892884 DOI: 10.3748/wjg.v21.i14.4323] [Cited by in CrossRef: 23] [Cited by in F6Publishing: 17] [Article Influence: 4.6] [Reference Citation Analysis]
9 Warshaw AL, Swanson RS. Pancreatic cancer in 1988. Possibilities and probabilities. Ann Surg 1988;208:541-53. [PMID: 2461172 DOI: 10.1097/00000658-198811000-00001] [Cited by in Crossref: 132] [Cited by in F6Publishing: 110] [Article Influence: 4.0] [Reference Citation Analysis]